CNS Pharmaceuticals, Inc. has filed 379 documents with the SEC available on Filing Fan. Browse annual reports (10-K), quarterly reports (10-Q), earnings releases (8-K), proxy statements, and more on Filing Fan. Filing Fan provides income statements, balance sheets, cash flow statements, and segment data parsed directly from EDGAR filings. All financial data is sourced from publicly available SEC regulatory filings.
| Form | Date | Description |
|---|---|---|
| 8-K | 2026-07-02 | Regulation FD Disclosure; Financial Statements and Exhibits |
| 424B3 | 2026-05-26 | 424B3 |
| 4 | 2026-05-20 | Statement of Changes in Beneficial Ownership |
| S-3 | 2026-05-19 | Registration Statement (Shelf) |
| D | 2026-05-19 | D |
| SC 13G/A | 2026-05-15 | Beneficial Ownership Report (Passive, Amended) |
| 10-Q | 2026-05-14 | Quarterly Report |
| 8-K | 2026-05-04 | Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities |
| 10-K/A | 2026-04-30 | Annual Report (Amended) |
| SCHEDULE 13G | 2026-04-17 | SCHEDULE 13G |